The present status of the blocked ontogeny hypothesis of neoplasia: the thalassemia connection.
D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000503:physiopathology; D002454:Cell Differentiation; D002455:Cell Division; D002478:Cells, Cultured; D004789:Enzyme Activation; D004815:Epidermal Growth Factor / Q000502:physiology; D004847:Epithelial Cells; D005319:Fetal Hemoglobin / Q000235:genetics; D005347:Fibroblasts / Q000166:cytology; D005786:Gene Expression Regulation; D006020:Glycopeptides / Q000502:physiology; D006131:Growth Inhibitors / Q000235:genetics; D006133:Growth Substances / Q000235:genetics / Q000502:physiology; D006454:Hemoglobins / Q000235:genetics; D006801:Humans; D007527:Isoenzymes / Q000235:genetics; D008099:Liver / Q000378:metabolism; D008954:Models, Biological; D009154:Mutation; D009369:Neoplasms / Q000235:genetics*; D010455:Peptides / Q000235:genetics; D011494:Protein Kinases / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics; D013789:Thalassemia / Q000235:genetics*; D014158:Transcription, Genetic; D015291:Transforming Growth Factors
D006020:Glycopeptides; D006131:Growth Inhibitors; D006133:Growth Substances; D006454:Hemoglobins; D007527:Isoenzymes; D010455:Peptides; D012333:RNA, Messenger; C017867:epidermal growth inhibitors; C020327:fibroblast proliferation inhibitor; D004815:Epidermal Growth Factor; D015291:Transforming Growth Factors; D005319:Fetal Hemoglobin; D011494:Protein Kinases